NCT00317759View on ClinicalTrials.gov

Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

October 31, 2008

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

therapeutic autologous lymphocytes

DRUG

fludarabine phosphate

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00317759 - Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter